• Explore /
  • Poster
  • / Ned-170: A combination anti-cancer therapy targeting late stage, heavily pre-treated solid tumor malignancies.

Ned-170: A combination anti-cancer therapy targeting late stage, heavily pre-treated solid tumor malignancies.

Abstract Poster

Authors

null

Edward Graeme Garmey

CMO Consulting, Inc., Concord, MA

Edward Graeme Garmey , Kristan Meetze , Bridget Martell

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Breakthrough

Session Type

Poster Session

Session Title

Poster Session B: Therapeutic Interventions and Treatment

Track

Therapeutic Interventions,Treatment

Sub Track

Treatment

Citation

J Glob Oncol 5, 2019 (suppl 1; abstr 141)

DOI

10.1200/JGO.2019.5.suppl.141

Abstract #

141

Poster Bd #

F3

Abstract Disclosures

Similar Posters

First Author: Ryan C Lynch

First Author: Makoto Nishio

First Author: Astrid van Barneveld

First Author: Bridget Adcock